Logo

ANP Technologies Pays Cogent Systems $500,000 to Co-Develop Biodetection System

Mar 02, 2005

NEW YORK, March 2 (GenomeWeb News) - ANP Technologies has paid Cogent Systems $500,000 for technology to be used in a low-cost rapid biological detection system, the companies said today.

 

Using Cogent's application-specific integrated circuit, including its pattern-recognition algorithm, ANP has built a detection system for the identification and quantification of biological agents, including B. anthracis spores and botulinum toxin, as well as biomarkers of certain diseases. Cogent also provides integration of automated data management and data mining software.

 

The detection system will be used by Department of Defense programs and agencies such as the Joint Service Water Monitor program, the Walter Reed Army Institute of Research, and the NavalMedicalResearchCenter.

 

ANP, a nanobiotechnology company and contractor for the US Army, is based in Newark, Del. Cogent is located in South Pasadena, Calif.

Breaking News
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.